4.3 Article

Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

SnapShot: Renal Cell Carcinoma

Christopher J. Ricketts et al.

CANCER CELL (2016)

Editorial Material Urology & Nephrology

KIDNEY CANCER Recurrence in renal cell carcinoma: the work is not done

Maxine Sun et al.

NATURE REVIEWS UROLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Renal cell carcinoma: staging and surveillance

N. Reed Dunnick

ABDOMINAL RADIOLOGY (2016)

Article Oncology

Cancer Statistics, 2015

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Biochemistry & Molecular Biology

Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer

Fernanda I. Staquicini et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Editorial Material Urology & Nephrology

Grading Renal Cell Carcinoma: The International Society of Urological Pathology Grading System

Peter A. Humphrey

JOURNAL OF UROLOGY (2014)

Article Pathology

Handling and Staging of Renal Cell Carcinoma

Kiril Trpkov et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Biochemistry & Molecular Biology

Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma

Yao-Hui Gao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase

DP Zelinski et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2002)